All In Biotech

Free tool

FAERS Monitor: Zevalin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125019 or its brand name (Zevalin, Ibritumomab Tiuxetan). Reports on generic versions are filed under their own applications.

Reports

1,523

Serious

1,418

93% of reports

Hospitalization

611

Death reported

551

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • thrombocytopenia174
  • sepsis172
  • neutropenia141
  • meningitis tuberculous128
  • myelodysplastic syndrome98
  • febrile neutropenia94
  • off label use93
  • progressive multifocal leukoencephalopathy90
  • disease progression85
  • anaemia84
  • platelet count decreased84
  • white blood cell count decreased83
  • pancytopenia78
  • pneumonia73
  • mucosal inflammation72

Reports by year received

View as table
YearReports
2004146
200556
200685
200769
200878
2009164
2010101
201175
201263
201347
201435
201576
201646
201764
201896
201949
202064
2021127
202221
202330
202414
202515
20262

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,636 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
meningitis tuberculousSignal1284105.23392.2401,804
progressive multifocal leukoencephalopathySignal90152.4124.613,242
myelodysplastic syndromeSignal9894.277.78,890
mucosal inflammationSignal7238.130.42,559
thrombocytopeniaSignal17421.518.73,397
sepsisSignal17221.318.53,325
febrile neutropeniaSignal9419.616.11,643
pancytopeniaSignal7819.315.51,337
neutropeniaSignal14114.312.21,745
platelet count decreasedSignal8410.98.8748
white blood cell count decreasedSignal8310.68.6714
disease progressionSignal859.98.1677
anaemiaSignal846.14.9355
pneumoniaSignal733.12.5104
off label use931.51.214

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.